Healix

Outcomes and Readmissions of Bacteremia, Endocarditis and Osteomyelitis among Patients Treated with Outpatient Parenteral Antimicrobial Therapy (OPAT) in Infectious Disease Physician Office Infusion Centers (POIC)

Authors:
Michael P. Dailey, MD – Infectious Disease Services of Georgia, Roswell, GA,
Richard C. Prokesch, MD – Infectious Diseases Associates, Riverdale, GA
John S. Adams, MD – Knoxville Infectious Disease Consultants, PC, Knoxville, TN
Lucinda J. Van Anglen, PharmD – Healix Infusion Therapy, Inc., Sugar Land, TX

View Poster

View All

Phase II and Phase III Studies

Healix regularly and actively supports Phase II and Phase III clinical trials in each of our specialty areas, including active studies in Multiple Sclerosis and Intestinal Bowel Disease.

For information on partnering with Healix on a study, please contact us.

FacebookTwitterLinkedInarrow1arcsearchiconowdtnotfound